Jonathan P Blatchford (Jon Blatchford)
Publication Activity (10 Years)
Years Active: 2016-2022
Publications (10 Years): 4
Publications (10 Years): 4
Boehringer Ingelheim Ltd
Sheffield Hallam University (MSC)
Affiliation History
Boehringer Ingelheim Ltd
United Kingdom
Quintiles Ltd
United Kingdom
GlaxoSmithKline
United Kingdom
Smithkline Beecham
United Kingdom
Pfizer Global Research and Development Europe
United Kingdom
Education History
Sheffield Hallam University
United Kingdom
University of Surrey
United Kingdom
Publications
- Carolyn S P Lam, Christiane E Angermann, John R Teerlink, Sean P Collins, Mikhail Naum Kosiborod, Jan Biegus, João Pedro Ferreira, Michael E Nassif, Mitchell A Psotka, Jasper Tromp, C Jan Willem Borleffs, Changsheng Ma, Joseph Comin-Colet, Michael Fu, Stefan P Janssens, Robert G Kiss, Robert J Mentz, Yasushi Sakata, Henrik Schirmer, Morten Schou, P Christian Schulze, Lenka Spinarova, Maurizio Volterrani, Jerzy Krzysztof Wranicz, Uwe Zeymer, Shelley Zieroth, Martina Brueckmann, Jonathan P Blatchford, Afshin Salsali, Piotr Ponikowski
- Mikhail Naum Kosiborod, Christiane E Angermann, Sean P Collins, John R Teerlink, Piotr Ponikowski, Jan Biegus, Josep Comín Colet, Joao Pedro Ferreira, Robert J Mentz, Michael E Nassif, Mitchell A Psotka, Jasper Tromp, Martina Brueckmann, Jonathan P Blatchford, Afshin Salsali, Carolyn S P Lam
- Jan Biegus, Adriaan A Voors, Sean P Collins, Mikhail N Kosiborod, John R Teerlink, Christiane E Angermann, Jasper Tromp, Joao Pedro Ferreira, Michael E Nassif, Mitchell A Psotka, Martina Brueckmann, Afshin Salsali, Jonathan P Blatchford, Piotr Ponikowski
- Christopher P Cannon, Savion Gropper, Deepak L Bhatt, Stephen G Ellis, Takeshi Kimura, Gregory Y H Lip, Ph Gabriel Steg, Jurriën M Ten Berg, Jenny Manassie, Jörg Kreuzer, Jonathan P Blatchford, Joseph M Massaro, Martina Brueckmann, Ernesto Ferreiros Ripoll, Jonas Oldgren, Stefan H Hohnloser, null nullDesign and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting. Clinical cardiology 39 (10) (2016)